
        <!DOCTYPE html>
    <html lang="ja">
    <style>
    body
    {
        color: black;
        background-color: white;
    }
    div{
        font-size: 14px;
    }
    span
    {
        font-size: 18px;
    }
    #grad1{
        background: linear-gradient(transparent 60%,#99e4f1 30%);
        font-size: 18px;
        font-weight: bold;
    }
    #grad2{
        background: linear-gradient(transparent 60%,#fda1a1 30%);
        font-size: 18px;
        font-weight: bold;
    }

    </style>

    <head>
        <meta charset="UTF-8">
        <title>105-248</title>
    </head>

    <body>
        <h1>
        <a href="./105_247.html" rel="external" title="prev">≪</a>
        105-248
        <a href="./105_249.html" rel="external" title="next">≫</a>
        </h1>
        <div class='problem'>
            <p>
                <span id="grad1">　問題文　</span>
            </p>
            <p>
                <p>55歳男性。コンピューター関連企業に勤務しており、勤務時間中は長時間コンピューターの画面を見ることが多い。1年前、目のかすみや視野がぼやけることがあり眼科を受診したところ、緑内障と診断され処方1にて治療を行っていた。</p>
<p>今回の受診の際、眼圧が高くなっていることを指摘され、処方2が追加となった。</p>
<p><img alt="" class="alignnone size-full wp-image-21160" height="168.7" loading="lazy" sizes="(max-width: 694px) 100vw, 694px" src="data:;base64,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" width="485.79999999999995"/></p>
<h4>問248</h4>
<p>追加された処方薬に対する薬剤師による指導内容として、適切なのはどれか。1つ選べ。</p>
<ol><li>同時に点眼する際には、処方2の薬剤を先に点眼すること。</li><li>点眼後は瞬きをして薬液を目の表面全体によくなじませること。</li><li>点眼直後に目がべたついた場合は、すぐに医師又は薬剤師に連絡すること。</li><li>点眼後に息苦しい感じがあったら、すぐに医師又は薬剤師に連絡すること。</li><li>副作用として血圧上昇に注意すること。</li></ol>
<h4>問249</h4>
<p>薬剤師による適切な指導内容の根拠として正しいのはどれか。1つ選べ。</p>
<ol><li>ぶどう膜強膜流出経路からの眼房水流出効果が持続する。</li><li>虹彩や眼瞼への色素沈着が起こる。</li><li>血漿浸透圧の上昇により眼房水産生が増加する。</li><li>アドレナリンβ受容体遮断効果が全身に及ぶ。</li><li>眼房水産生に対する抑制効果が持続する。</li></ol>    
            </p>
        </div>
        <hr>

        <input type="button" value="check ans" onclick="toggle_switch()"/>
        
        <div id='toggle'>
        <div class='answer'>
            <p>
                <span id="grad2">　解答　　</span>
            </p>
            <p>
            問248：4問249：4
            </p>
        </div>
        <div class='description'>
            <p>
                <span id="grad2">　解説　　</span>
            </p>
            <h4>問248</h4>
<p>問249 と合わせて解説します。</p>
<h4>問249</h4>
<p>チモプトールは、「β 遮断作用」があり、気管支喘息、又はその既往歴のある患者に禁忌です。又、コントロール不十分な心不全などの心疾患も、症状を憎悪させるおそれがあるため禁忌です。</p>
<p>問 248 ですが<br/>息苦しさがあった場合に連絡をするよう指導するのが適切と考えられます。</p>
<p>ちなみにですが、同時に点眼する場合は、追加されたチモブトール XE は、ゲル化することにより持続性を実現しています。先に点眼してしまうと、後の目薬がはじかれて、適切に指すことが難しいと考えられます。従って、処方 2 が後です。</p>
<p>問 249 については「全身性の β 遮断による効果」です。</p>
<p>以上より<br/>問 248 の正解は 4 です。<br/>問 249 の正解は 4 です。</p>
<p>類題 </p>
            </p>
        </div>
        </div>
    </body>
    <script>
    document.getElementById("toggle").style.display="none";
    function toggle_switch(){
        var x = document.getElementById("toggle");
        if (x.style.display=="block"){
            x.style.display="none";
        }
        else{
            x.style.display="block";
        }
    }
    </script>
    